Street Talk: Summer No Picnic for Investors - At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going - BioPharm

ADVERTISEMENT

Street Talk: Summer No Picnic for Investors
At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going


BioPharm International
Volume 21, Issue 9

IT EXPLAINS A LOT

What to do? Sitting this one out and putting your money into treasuries seems like good common sense. And know that this crisis, too, shall pass. Capital markets have a way of dealing with excess, like we saw with the dotcoms in 1999 and 2000, and with the subprime credit markets today. The market tends to square things away pretty efficiently, even though a lot of people get hurt.

The name of the game is not to be one of those people.

Celebrity author and business/finance commentator for CNN and Fox News, Brian O'Connell has written for The Wall Street Journal and Newsweek, Doylestown, PA, 267.880.3144,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Publishes Guidance on ANDA Submissions
July 10, 2014
EMA Recommends 39 Drugs in First Half of 2014
July 10, 2014
Biotech Industry Forms International Council
July 10, 2014
Novartis Personalized Cell Therapy Receives FDA Breakthrough Therapy Designation
July 9, 2014
FDA Urged to Preserve Biosimilar Naming Conventions
July 2, 2014
Author Guidelines
Source: BioPharm International,
Click here